| Measure Title: |
RELATING TO ACCESS TO TREATMENT FOR TERMINALLY ILL PATIENTS.
|
| Report Title: |
Right-to-Try Act; Terminally Ill Patients; Investigational Drugs; Biological Products
|
| Description: |
Beginning on January 1, 2025, permits manufacturers of investigational drugs or biological products to make these drugs and products available to terminally ill patients under certain conditions.
|
| Companion: |
SB2023
|
| Package: |
None
|
| Current Referral: |
HLT, CPC
|
| Introducer(s): |
HUSSEY-BURDICK, PIERICK, Kapela, Perruso
|
| Act: |
|
| Sort by Date | | Status Text |
| 1/24/2024 | H | Referred to HLT, CPC, referral sheet 2 |
| 1/22/2024 | H | Introduced and Pass First Reading. |
| 1/19/2024 | H | Pending introduction. |
S = Senate |
H = House |
D = Data Systems |
$ = Appropriation measure |
ConAm = Constitutional Amendment
Some of the above items require Adobe Acrobat Reader. Please visit
Adobe's download page
for detailed instructions.
HB2024